This may be related to increased reactive oxygen species (ROS) production and activation of fatty acid synthesis, such as via fatty acid synthetase [34], and pancreatic cancers with KRAS mutations may be expected to have increased lipid peroxidation from GPX4 inhibition. This evidence concerns the gene GPX4 and familial pancreatic carcinoma.